Association of Cigarette Smoking With HIV Prognosis Among Women in the HAART Era: A Report From the Womens Interagency HIV Study
Joseph G. Feldman, DrPH,
Howard Minkoff, MD,
Michael F. Schneider, MS,
Stephen J. Gange, PhD,
Mardge Cohen, MD,
D. Heather Watts, MD,
Monica Gandhi, MD,
Robert S. Mocharnuk, MD and
Kathryn Anastos, MD
Joseph G. Feldman is with the Department of Preventive Medicine and Community Health, SUNY Health Sciences Center at Brooklyn, New York, NY. Howard Minkoff is with the Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Health Sciences Center at Brooklyn. Michael F. Schneider and Stephen J. Gange are with the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. Mardge Cohen is with Cook County Hospital, Chicago, Ill. D. Heather Watts is with Pediatric, Adolescent and Maternal AIDS, National Institute of Child Health and Human Development, Bethesda, Md. Monica Gandhi is with the Department of Medicine, University of California, San Francisco, Calif. Robert S. Mocharnuk is with the University of Southern California, Keck School of Medicine, Los Angeles. Kathryn Anastos is with the departments of Medicine and Epidemiology and Population Health, Montefiore Medical Center, Bronx, NY.
FIGURE 2—Cumulative percentage remaining free from an AIDS-defining condition (a) and surviving (b), by smoking status before highly active antiretroviral therapy initiation.